Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Thalidomide in Advanced HCC
NCT00971126Phase 2Terminated
- Sponsor
- National Health Research Institutes
- Start
- Jul 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in hepatocellular carcinoma (HCC), sponsored by National Health Research Institutes. Started Jul 2009; status: terminated.
02
Drugs
thalidomide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00971126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00971126.